Trials for AstraZeneca’s new ‘antibody cocktail’ treatment will begin in the UK
Trials for AstraZeneca’s new ‘antibody cocktail’ treatment will begin in the UK – and it could prevent Covid-19 from developing for up to a year. A participant in Manchester will be the first in the world to receive the pharmaceutical company’s new ‘antibody cocktail’ as part of the trial to test its effectiveness. The clinical … Read more